Synthetic-peptide-based enzyme-linked immunosorbent assay for screening human serum or plasma for antibodies to human immunodeficiency virus type 1 and type 2

Clinical and Diagnostic Laboratory Immunology

Volumn 4, Issue 5, 1997, Pages 598-603

  Gonzalez, Lisette ^a   Boyle, Rosanne W ^a   Zhang, Meilun ^a   Castillo, Jonathan ^a   Whittier, Susan ^b   Della Latta, Phyllis ^b   Clarke, Lorraine M ^c   George, J Richard ^d   Fang, Xinde ^a   Wang, James G ^a   Hosein, Barbara ^a   Wang, Chang Yi ^a  

^a United Biomedical Inc   (United States)

^b New York Presbyterian Hospital Columbia University Medical Center   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SYNTHETIC PEPTIDE;

ANTIBODY DETECTION; ARTICLE; BLOOD BANK; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; NONHUMAN; PLASMA; PRIORITY JOURNAL; SCREENING; SERODIAGNOSIS; SERUM;

EID: 12644281618     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.4.5.598-603.1997     Document Type: Article

References (17)

1. Allain, J. P., D. A. Paul, Y. Laurian, D. Senn, and Members of the AIDS Haemophilia French Study Group. 1986. Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs. Lancet ii: 1233-1236.
2. Cabradilla, C. D., J. E. Groopman, J. Lanigan, M. Renz, L. A. Lasky, and D. J. Capon. 1985. Serodiagnosis of antibodies to the human AIDS retrovirus with a bacterially synthesized polypeptide. Biotechnology 4:1228-1231.
3. Cambridge Biotech Corporation. Product insert. Cambridge Biotech UIV-1 Western blot kit for detection of antibodies to HIV-1. Cambridge Biotech Corporation, Worcester, Mass.
4. Centers for Disease Control. 1989. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. Morbid. Mortal. Weekly Rep. 38:1-7.
5. Chang, N. T., P. K. Chanda, A. D. Varone, S. McKinney, D. P. Rhodes, S. H. Tam, C. W. Shearman, J. Huang, T. W. Chang, R. C. Gallo, and F. Wong-Staal. 1985. Expression in Escherichia coli of open reading frame gene segments of HTLV-III. Science 228:93-96.
6. Dock, N. L., S. H. Kleinman, M. A. Rayfield, C. A. Sellable, A. E. Williams, and R. Y. Dodd. 1991. Human immunodeficiency virus infection and indeterminate Western blot patterns. Prospective studies in a low prevalence population. Arch. Intern. Med. 151:525-530.
7. Gaines, H., A. Sönnerborg, J. Czajkowski, F. Chiodi, E. M. Fenyö, M. VonSydow, J. Alpert, P. O. Pehrson, L. Moberg, B. Åsjö, and M. Forsgren. 1987. Antibody response in primary human immunodeficiency virus infection. Lancet i:1249-1253.
8. Henderson, L. E., R. Sowder, T. D. Copeland, S. Oroszlan, L. O. Arthur, W. G. Robey, and P. Fischinger. 1987. Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III. J. Virol. 61:629-632.
9. Jackson, J. B., K. L. MacDonald, J. Caldwell, C. Sullivan, W. E. Kline, M. Hanson, K. J. Sannerud, S. L. Stramer, N. J. Fildes, S. Y. Kwok, J. J. Sninsky, R. J. Bowman, H. F. Polesky, H. H. Balfour, and M. T. Osterholm. 1990. Absence of HIV infection in blood donors with indeterminate Western blot tests for antibody to HIV-1. N. Engl. J. Med. 322:217-222.
10. Kühnl, P., S. Seidl, and G. Holzberger. 1985. HLA DR4 antibodies cause positive HTLV-III antibody ELISA results. Lancet ii:1222-1223.
11. Leitman, S. F., H. G. Klein, J. J. Melpolder, E. J. Read, J. J. Esteban, E. M. Leonard, L. Harvath, J. W.-K. Shih, R. Nealon, J. Foy, F. Darr, and H. J. Alter. 1989. Clinical implications of positive tests for antibodies to human immunodeficiency virus type 1 in asymptomatic blood donors. N. Engl. J. Med. 321:917-924.
12. Louwagie, J., F. E. McCutchan, M. Peeters, T. P. Breenan, E. Sander-Buell, G. A. Eddy, G. van der Groen, K. Fransen, G.-M. Gershy-Damet, R. Deleys, and D. S. Burke. 1993. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 7:769-780.
13. Sayers, M. H., P. G. Beatty, and J. A. Hausen. HLA antibodies as a cause of false-positive reactions in screening enzyme immunoassays for antibodies to human T-lymphotropic virus type III. 1986. Transfusion 26:113-115.
14. Vercuateren, G. 1994. Personal communication.
15. Wang, C. Y. 1988. Synthetic-peptide-bascd immunodiagnosis of retrovirus infections: current status and future prospects. Adv. Biotechnol. Processes 10:131-148.
16. Wang, J. J. G., S. Steel, R. Wisniewolski, and C. Y. Wang. 1986. Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein. Proc. Natl. Acad. Sci. USA 83:6159-6163.
17. Zaaijer, H. L., P. van Exel-Oehlers, T. Kraaijevcld, E. Altena, and P. N. Lelie. 1992. Early detection of antibodies to HIV-1 by third-generation assays. Lancet 340:770-772.